Myomo, Inc. (MYO)
NYSEAMERICAN: MYO · IEX Real-Time Price · USD
3.860
+0.110 (2.93%)
May 21, 2024, 4:00 PM EDT - Market closed
Myomo Revenue
Myomo had revenue of $19.55M in the twelve months ending March 31, 2024, with 29.17% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $3.75M with 8.93% year-over-year growth. In the year 2023, Myomo had annual revenue of $19.24M with 23.70% growth.
Revenue (ttm)
$19.55M
Revenue Growth
+29.17%
P/S Ratio
5.69
Revenue / Employee
$193,553
Employees
101
Market Cap
111.22M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 19.24M | 3.69M | 23.70% |
Dec 31, 2022 | 15.56M | 1.70M | 12.26% |
Dec 31, 2021 | 13.86M | 6.27M | 82.72% |
Dec 31, 2020 | 7.58M | 3.75M | 97.60% |
Dec 31, 2019 | 3.84M | 1.39M | 57.02% |
Dec 31, 2018 | 2.44M | 885.24K | 56.79% |
Dec 31, 2017 | 1.56M | 455.59K | 41.29% |
Dec 31, 2016 | 1.10M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
111, Inc. | 2.11B |
Sensus Healthcare | 31.66M |
KORU Medical Systems | 29.32M |
BeyondSpring | 1.75M |
Genelux | 8.00K |
MYO News
- 13 days ago - Myomo Reports First Quarter 2024 Financial Results - Business Wire
- 15 days ago - Myomo Announces First Lump Sum Reimbursements for MyoPros Delivered to Medicare Part B Beneficiaries Under New CMS Fees - Business Wire
- 20 days ago - Myomo to Report First Quarter Financial Results on May 8, 2024 - Business Wire
- 7 weeks ago - Myomo Appoints Heather Getz to its Board of Directors - Business Wire
- 2 months ago - Myomo Reports Fourth Quarter and Full Year 2023 Financial Results - Business Wire
- 2 months ago - CMS Posts Final Medicare DMEPOS Fee Schedule Rate for the MyoPro® - Business Wire
- 2 months ago - Myomo to Report Fourth Quarter Financial Results on March 7, 2024 - Business Wire
- 4 months ago - Myomo Announces Closing of $6 Million Registered Direct Offering of Common Stock Priced At-the-Market - Business Wire